JPS56138110A - Suppository containing citric acid or salt thereof - Google Patents

Suppository containing citric acid or salt thereof

Info

Publication number
JPS56138110A
JPS56138110A JP3899580A JP3899580A JPS56138110A JP S56138110 A JPS56138110 A JP S56138110A JP 3899580 A JP3899580 A JP 3899580A JP 3899580 A JP3899580 A JP 3899580A JP S56138110 A JPS56138110 A JP S56138110A
Authority
JP
Japan
Prior art keywords
citric acid
suppository
salt
medicament
citrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3899580A
Other languages
Japanese (ja)
Inventor
Kunio Sekine
Yoshiki Suzuki
Gentaro Yamashita
Hisao Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP3899580A priority Critical patent/JPS56138110A/en
Publication of JPS56138110A publication Critical patent/JPS56138110A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PURPOSE: A suppository, having improved absorptivity and containing a medicament and citric acid or a salt thereof.
CONSTITUTION: A suppository contains a medicament and citric acid and/or a citrate, e.g. sodium citrate. The medicament is particularly a peptide hormone, e.g. insulin or calcitonin, enzyme, polysaccharide, carcinostatic agent or antibiotic which is, practically little or only insufficiently, absorbed by the conventional rectal or oral administration. The use of these medicaments as the suppository obtained in the form of a uniform mixture with citric acid and/or a citrate permits their effective absorption through a rectrum and therefore their administration to a patient even without injection.
COPYRIGHT: (C)1981,JPO&Japio
JP3899580A 1980-03-28 1980-03-28 Suppository containing citric acid or salt thereof Pending JPS56138110A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3899580A JPS56138110A (en) 1980-03-28 1980-03-28 Suppository containing citric acid or salt thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3899580A JPS56138110A (en) 1980-03-28 1980-03-28 Suppository containing citric acid or salt thereof

Publications (1)

Publication Number Publication Date
JPS56138110A true JPS56138110A (en) 1981-10-28

Family

ID=12540707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3899580A Pending JPS56138110A (en) 1980-03-28 1980-03-28 Suppository containing citric acid or salt thereof

Country Status (1)

Country Link
JP (1) JPS56138110A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0067513A2 (en) * 1981-05-14 1982-12-22 Takeda Chemical Industries, Ltd. Pharmaceutical preparations containing TRH or its analogue
EP0427998A2 (en) * 1989-11-16 1991-05-22 PHIDEA S.p.A. A pharmaceutical composition for rectal administration of calcitonin
US5021241A (en) * 1983-10-14 1991-06-04 Sumitomo Pharmaceuticals Company, Limited Long-term sustained-release preparation
WO1991017742A1 (en) * 1988-12-07 1991-11-28 Ss Pharmaceutical Co., Ltd. Sustained release suppository
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
AT396424B (en) * 1987-09-15 1993-09-27 Sandoz Ag CALCITON INSUPPOSITORIES
WO2002034293A3 (en) * 2000-10-23 2003-03-13 Shanbrom Tech Llc Use of citric acid as antimicrobial agent or enhancer or as anticancer agent
US7521069B2 (en) * 1994-03-07 2009-04-21 Novartis Ag Methods and compositions for pulmonary delivery of insulin

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55153712A (en) * 1979-05-18 1980-11-29 Kao Corp Insulin pharmaceutical preparation and its production
JPS5675423A (en) * 1979-11-21 1981-06-22 Kao Corp Physiologically active high polymer substance-containing composition for mucosa administration and its preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55153712A (en) * 1979-05-18 1980-11-29 Kao Corp Insulin pharmaceutical preparation and its production
JPS5675423A (en) * 1979-11-21 1981-06-22 Kao Corp Physiologically active high polymer substance-containing composition for mucosa administration and its preparation

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0067513A2 (en) * 1981-05-14 1982-12-22 Takeda Chemical Industries, Ltd. Pharmaceutical preparations containing TRH or its analogue
US5021241A (en) * 1983-10-14 1991-06-04 Sumitomo Pharmaceuticals Company, Limited Long-term sustained-release preparation
AT396424B (en) * 1987-09-15 1993-09-27 Sandoz Ag CALCITON INSUPPOSITORIES
WO1991017742A1 (en) * 1988-12-07 1991-11-28 Ss Pharmaceutical Co., Ltd. Sustained release suppository
US5500221A (en) * 1988-12-07 1996-03-19 Ss Pharmaceutical Co., Ltd. Sustained release suppository
EP0427998A2 (en) * 1989-11-16 1991-05-22 PHIDEA S.p.A. A pharmaceutical composition for rectal administration of calcitonin
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US7521069B2 (en) * 1994-03-07 2009-04-21 Novartis Ag Methods and compositions for pulmonary delivery of insulin
WO2002034293A3 (en) * 2000-10-23 2003-03-13 Shanbrom Tech Llc Use of citric acid as antimicrobial agent or enhancer or as anticancer agent

Similar Documents

Publication Publication Date Title
JPS53113008A (en) Constant rate releasing preparation
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
CA2336945A1 (en) Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
JPS56138111A (en) Suppository containing unsaturated fatty acid or salt thereof
GR78416B (en)
JPS56138110A (en) Suppository containing citric acid or salt thereof
SE8204873L (en) PHARMACEUTICAL PREPARATIONS, INCLUDING HUMAN INSULIN AND HUMAN C-PEPTIDE
JPS5551020A (en) Remedy for rheumatism
JPS56138112A (en) Suppository containing ascorbic acid or sodium ascorbate
KR920702225A (en) Pharmaceutical composition
JPS56138115A (en) Suppository containing acidic amino acid or derivative thereof
JPS55122715A (en) Antidiabetic agent
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
JPS56122310A (en) Suppository
JPS57144214A (en) Pharmaceutical preparation for rectum medication
MY101916A (en) Etoposide oral dosage form.
JPS5470428A (en) Carcinostatic agent
JPS53148518A (en) Stabilized prostaglandin e composition and its preparation
JPS57158719A (en) Rectal administration pharmaceutical
KR830008678A (en) Analgesic composition
JPS5639019A (en) Antiviral agent
JPS646214A (en) Remedy for ulcerative colonopathy
JPS5569510A (en) Carcinostatic agent
JPS5341418A (en) Preparation of antibiotic preparations of aminoglycoside series suitable for rectal administration
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide